Sign in
4

Changes in Ownership

Bone Biologics Corp Filed Acc 0001493152-23-006965

Options or other derivatives

  • Chief Financial Officer acquired 18,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walsh Deina H · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-25 Grant or award : show line 1 in the form Employee Stock Option +18,875 43,875 D
Loading xslF345X03/ownership.xml…